Connection
Sean Donahue to Angiogenesis Inhibitors
This is a "connection" page, showing publications Sean Donahue has written about Angiogenesis Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.362 |
|
|
|
-
Donahue SP, Recchia F, Sternberg P. Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. Am J Ophthalmol. 2010 Aug; 150(2):287; author reply 287.
Score: 0.292
-
Law JC, Recchia FM, Morrison DG, Donahue SP, Estes RL. Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. J AAPOS. 2010 Feb; 14(1):6-10.
Score: 0.070